Dr. Paul B. Fisher, Professor and Chairman, Department of Human and Molecular Genetics, Director, VCU Institute of Molecular Medicine Thelma Newmeyer Corman Chair in Cancer Research in the VCU Massey Cancer Center, VCU, School of Medicine, Richmond, VA, and Emeritus Professor, Columbia University, College of Physicians & Surgeons, New York, NY. He published over 650 papers and reviews, is among the top NIH/NCI funded investigators and has 55 issued patents. He pioneered novel gene/discovery approaches, developed innovative therapeutic approaches, presented numerous named and distinguished lectures, founded several start-up companies, was Virginia Outstanding Scientist of 2014, and elected to the National Academy of Inventors in 2018. Dr. Fisher is a successful seasoned entrepreneur. He founded GenQuest Incorporated, a functional genomics company, which merged with Corixa Corporation in 1998, traded on NASDAQ and was acquired by GlaxoSmithKline in 2006. He co-founded (2017/2018) InVaMet Therapeutics (IVMT), developing small molecule inhibitors of metastasis, and InterLeukin Combinatorial Therapies (ILCT), moving therapeutic interleukins/cytokines from bench-to-bedside.